• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
  • N S D L
    1,298.70 1,425.00(%)
  • Ola Electric
    59.38 39.58(%)
  • Netweb Technol.
    3,180.10 3,180.10(%)
  • Indus Towers
    341.75 444.45(%)
  • Vodafone Idea
    7.45 15.22(%)
  • Moschip Tech.
    258.25 279.00(%)
  • Godfrey Phillips
    11,150.00 11,462.00(%)
  • Vimta Labs
    902.85 902.85(%)
  • G M D C
    515.00 515.00(%)
  • Fiem Industries
    2,005.00 1,156.00(%)
  • One Mobikwik
    309.00 698.30(%)
  • Brainbees Solut.
    407.80 734.25(%)
  • Apollo Micro Sys
    298.65 88.10(%)
  • Avantel
    180.20 191.01(%)
  • Swiggy
    440.00 617.00(%)
  • TCS
    3,029.50 2,992.05(%)
  • Eternal Ltd
    334.40 334.40(%)
  • L&T Finance Ltd
    232.85 232.85(%)
  • Reliance Industr
    1,380.80 1,551.00(%)
  • Kross Ltd
    235.00 271.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mangalam Drugs and Organics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20249.0
  • ISIN : INE584F01014
78.77 1 (1.69%)
  • As on 06 Sep 2025 (EOD)

  • Today’s Low

    77.40

  • Today’s High

    79.70

  • Open

    77.46

  • Perv Close

    77.46

  • 52W Low

    70.10

  • 52W High

    140.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    124.68

  • Div & Yield %

    0.00

  • Book Value(₹)

    93.92

  • Debt-Equity Ratio

    1.69

  • AGM Date

    05-Sep-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.78

  • Mar.Cap (₹Cr.)

    124.68

  • RONW (%)

    -6.68

  • ROCE (%)

    1.16

Score Board

  • Equity (₹ in Cr.)

    15.83

  • BV (₹)

    93.90

  • Sales( ₹ in Cr.)

    317.58

  • NP (in Cr.)

    6.92

  • NP Var(%)

    177.0

  • Div%

    0.0

  • CPS (₹)

    14.70

  • EPS (₹)

    4.40

  • Traded Value (₹ in Lakhs)

    124.14

  • 52 Week High

    140.50

  • 52 Week Low

    70.10

  • Price BSE

    78.0

  • Price NSE

    79.00

  • Market Capital( in Cr.)

    124.14

  • P/C Ratio

    5.30

  • P/E Ratio

    17.80

  • Price Vs.BV

    4.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 368.59 372.25 451.07 379.98 313.13 258.81
Excise Duty 0.00 0.00 0.00 0.00 30.78 31.23
Net Sales 368.59 372.25 451.07 379.98 282.35 227.58
Other Income 0.10 0.44 0.09 4.72 1.18 0.32
Stock Adjustments -9.10 42.16 33.75 4.23 -17.28 15.39
Total Income 359.59 414.85 484.91 388.93 266.25 243.29
EXPENDITURE :            
Raw Materials 235.41 292.60 340.39 256.19 178.07 168.70
Power and Fuel Cost 28.50 25.59 22.90 16.12 14.24 14.56
Employee Cost 39.07 34.61 37.25 29.88 26.04 25.82
Other Manufacturing Expenses 13.26 11.58 11.92 8.11 7.37 6.86
Selling and Administration Expenses 13.10 11.60 13.64 16.19 14.24 17.02
Miscellaneous Expenses 12.76 12.71 9.67 4.42 1.42 0.32
Employee Benefit Expenses 39.07 34.61 37.25 29.88 26.04 25.82
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 342.10 388.69 435.77 330.91 241.38 233.29
Operating Profit 17.49 26.16 49.14 58.02 24.87 10.00
Interest 13.92 12.96 11.16 9.33 10.40 8.65
Gross Profit 3.57 13.20 37.98 48.69 14.47 1.35
Depreciation 14.63 10.99 10.25 9.18 8.22 7.09
Profit Before Tax -11.06 2.21 27.73 39.51 6.25 -5.74
Current Tax 0.19 -0.03 8.81 9.27 0.05 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.20 0.97 -0.73 2.28 -2.05 2.29
Reported Net Profit -9.05 1.27 19.66 27.97 8.25 -8.03
Extraordinary Items -0.05 0.00 0.06 0.00 -0.04 -0.03
Adjusted Net Profit -9.00 1.27 19.60 27.97 8.29 -8.00
Adjustment below Net Profit -0.56 0.12 0.12 -1.12 0.02 -0.08
P & L Balance brought forward 102.96 101.57 81.79 54.94 46.67 54.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 93.35 102.96 101.57 81.79 54.94 46.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -5.72 0.80 12.42 17.67 5.21 0.00
Earnings Per Share(Adj)-Unit Curr -5.72 0.80 12.42 17.67 5.21 0.00
Book Value 89.93 96.00 95.12 82.63 65.67 60.44
Book Value(Adj)-Unit Curr 89.93 96.00 95.12 82.63 65.67 60.44

Shareholding Pattern

  • Promoter Group

    50.30%

  • Public Share Holding

    49.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,951,698 31.28 4,951,698 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,010,348 19.02 3,010,348 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,962,046 50.30 7,962,046 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 306 0.00 306 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 84,498 0.53 84,498 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 84,804 0.54 84,804 5
2] Non Institution
Bodies Corporate 293,136 1.85 293,136 68
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 167,817 1.06 167,817 322
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,475 0.02 2,475 3
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,110,071 13.33 2,110,071 41
Individuals holding nominal share capital up to Rs. 1 lakh 4,938,184 31.20 4,938,174 18,974
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,781,398 49.16 7,781,388 19,705
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,828,248 100.00 15,828,238 19,728

Company Background

Mangalam Drugs and Organics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mangalam Drugs and Organics Ltd
  • BSE Code : 20249.0
  • ISIN : INE584F01014

  • Incorporation Year

    1972

  • Registered Office

    3rd Floor Rupam Building
    239 P D Mello Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22616200/6300/8787

  • FAX

    91-22-26190900

  • Chairman

    Govardhan M Dhoot

  • Managing Director

    Govardhan M Dhoot

  • Company Secretary

    Anuradha Pandey

  • Auditor

    V S Somani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Mangalam Drugs and Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mangalam Drugs 78.43 368.69 368.59 -13.09 1.16
Abbott India 31,179.05 6,684.73 6,409.15 45.62 44.95
Astrazeneca Phar 9,088.15 1,756.92 1,716.29 123.92 32.94
P & G Health Ltd 6,465.40 944.52 934.17 35.70 40.23
Glaxosmi. Pharma 2,770.30 3,866.05 3,723.49 49.82 58.72
Cipla 1,553.30 20,029.57 19,044.85 23.21 21.40
Amrutanjan Healt 769.30 469.50 451.82 40.79 21.89
Guj. Themis Bio. 383.80 152.47 150.80 93.84 27.21
Fermenta Biotec. 334.60 442.21 430.53 11.10 17.61
Bliss GVS Pharma 156.00 703.42 667.20 23.32 9.16
Ambalal Sarabhai 32.39 19.33 4.04 16.96 2.10